Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 561

1.

Cardiac amyloid in patients with familial amyloid polyneuropathy consists of abundant wild-type transthyretin.

Yazaki M, Tokuda T, Nakamura A, Higashikata T, Koyama J, Higuchi K, Harihara Y, Baba S, Kametani F, Ikeda S.

Biochem Biophys Res Commun. 2000 Aug 11;274(3):702-6.

PMID:
10924339
2.

Contribution of wild-type transthyretin to hereditary peripheral nerve amyloid.

Yazaki M, Liepnieks JJ, Kincaid JC, Benson MD.

Muscle Nerve. 2003 Oct;28(4):438-42.

PMID:
14506715
3.

Progressive wild-type transthyretin deposition after liver transplantation preferentially occurs onto myocardium in FAP patients.

Yazaki M, Mitsuhashi S, Tokuda T, Kametani F, Takei YI, Koyama J, Kawamorita A, Kanno H, Ikeda SI.

Am J Transplant. 2007 Jan;7(1):235-42. Epub 2006 Oct 25.

4.
5.

Presence of variant transthyretin in aqueous humor of a patient with familial amyloidotic polyneuropathy after liver transplantation.

Haraoka K, Ando Y, Ando E, Sun X, Nakamura M, Terazaki H, Misumi S, Tanoue Y, Tajiri T, Shoji S, Ishizaki T, Okabe H, Tanihara H.

Amyloid. 2002 Dec;9(4):247-51.

PMID:
12557753
6.

Progressive cardiac amyloidosis following liver transplantation for familial amyloid polyneuropathy: implications for amyloid fibrillogenesis.

Stangou AJ, Hawkins PN, Heaton ND, Rela M, Monaghan M, Nihoyannopoulos P, O'Grady J, Pepys MB, Williams R.

Transplantation. 1998 Jul 27;66(2):229-33.

PMID:
9701270
7.

Familial transthyretin-type amyloid polyneuropathy in Japan: clinical and genetic heterogeneity.

Ikeda S, Nakazato M, Ando Y, Sobue G.

Neurology. 2002 Apr 9;58(7):1001-7. Review.

PMID:
11940682
8.

Wild-type transthyretin significantly contributes to the formation of amyloid fibrils in familial amyloid polyneuropathy patients with amyloidogenic transthyretin Val30Met.

Tsuchiya-Suzuki A, Yazaki M, Kametani F, Sekijima Y, Ikeda S.

Hum Pathol. 2011 Feb;42(2):236-43. doi: 10.1016/j.humpath.2010.06.014. Epub 2010 Nov 5.

PMID:
21056899
9.
10.

Vitreous amyloidosis after liver transplantation in patients with familial amyloid polyneuropathy: ocular synthesis of mutant transthyretin.

Munar-Qués M, Salva-Ladaria L, Mulet-Perera P, Solé M, López-Andreu FR, Saraiva MJ.

Amyloid. 2000 Dec;7(4):266-9.

PMID:
11132095
11.

Clinical and pathological studies of cardiac amyloidosis in transthyretin type familial amyloid polyneuropathy.

Hattori T, Takei Y, Koyama J, Nakazato M, Ikeda S.

Amyloid. 2003 Dec;10(4):229-39.

PMID:
14986482
12.

Familial amyloid polyneuropathy type I (Portuguese): distribution and characterization of renal amyloid deposits.

Lobato L, Beirão I, Guimarães SM, Droz D, Guimarães S, Grünfeld JP, Noël LH.

Am J Kidney Dis. 1998 Jun;31(6):940-6.

PMID:
9631837
13.

A different amyloid formation mechanism: de novo oculoleptomeningeal amyloid deposits after liver transplantation.

Ando Y, Terazaki H, Nakamura M, Ando E, Haraoka K, Yamashita T, Ueda M, Okabe H, Sasaki Y, Tanihara H, Uchino M, Inomata Y.

Transplantation. 2004 Feb 15;77(3):345-9.

PMID:
14966406
14.

Deposition of transthyretin amyloid is not accelerated by the same amyloid in vivo.

Wei L, Kawano H, Fu X, Cui D, Ito S, Yamamura K, Ishihara T, Tokuda T, Higuchi K, Maeda S.

Amyloid. 2004 Jun;11(2):113-20.

PMID:
15478467
15.

Deposition and passage of transthyretin through the blood-nerve barrier in recipients of familial amyloid polyneuropathy livers.

Sousa MM, Ferrão J, Fernandes R, Guimarães A, Geraldes JB, Perdigoto R, Tomé L, Mota O, Negrão L, Furtado AL, Saraiva MJ.

Lab Invest. 2004 Jul;84(7):865-73.

16.

Late-onset familial amyloid polyneuropathy type I (transthyretin Met30-associated familial amyloid polyneuropathy) unrelated to endemic focus in Japan. Clinicopathological and genetic features.

Misu Ki, Hattori N, Nagamatsu M, Ikeda Si, Ando Y, Nakazato M, Takei Yi, Hanyu N, Usui Y, Tanaka F, Harada T, Inukai A, Hashizume Y, Sobue G.

Brain. 1999 Oct;122 ( Pt 10):1951-62.

17.
18.

Progression of transthyretin amyloid neuropathy after liver transplantation.

Liepnieks JJ, Zhang LQ, Benson MD.

Neurology. 2010 Jul 27;75(4):324-7. doi: 10.1212/WNL.0b013e3181ea15d4.

19.

'In vitro' amyloid fibril formation from transthyretin: the influence of ions and the amyloidogenicity of TTR variants.

Bonifácio MJ, Sakaki Y, Saraiva MJ.

Biochim Biophys Acta. 1996 May 24;1316(1):35-42.

PMID:
8634341
20.

Genetic abnormalities and pathogenesis of familial amyloidotic polyneuropathy.

Murakami T, Uchino M, Ando M.

Pathol Int. 1995 Jan;45(1):1-9. Review.

PMID:
7704238
Items per page

Supplemental Content

Write to the Help Desk